Stams T, Nair S K, Okuyama T, Waheed A, Sly W S, Christianson D W
Department of Chemistry, University of Pennsylvania, Philadelphia 19104-6323, USA.
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13589-94. doi: 10.1073/pnas.93.24.13589.
It has recently been demonstrated that the C-terminal deletion mutant of recombinant human carbonic anhydrase IV (G267X CA IV) converts the normally glycosylphosphatidylinositol-anchored enzyme into a soluble secretory form which has the same catalytic properties as the membrane-associated enzyme purified from human tissues. We have determined the three-dimensional structure of the secretory form of human CA IV by x-ray crystallographic methods to a resolution of 2.8 A. Although the zinc binding site and the hydrophobic substrate binding pocket of CA IV are generally similar to those of other mammalian isozymes, unique structural differences are found elsewhere in the active site. Two disufide linkages, Cys-6-Cys-11G and Cys-23-Cys-203, stabilize the conformation of the N-terminal domain. The latter disulfide additionally stabilizes an active site loop containing a cis-peptide linkage between Pro-201 and Thr-202 (this loop contains catalytic residue Thr-199). On the opposite side of the active site, the Val-131-Asp-136 segment adopts an extended loop conformation instead of an alpha-helix conformation as found in other isozymes. Finally, the C terminus is surrounded by a substantial electropositive surface potential, which is likely to stabilize the interaction of CA IV with the negatively charged phospholipid headgroups of the membrane. These structural features are unique to CA IV and provide a framework for the design of sulfonamide inhibitors selective for this particular isozyme.
最近有研究表明,重组人碳酸酐酶IV的C末端缺失突变体(G267X CA IV)可将通常以糖基磷脂酰肌醇锚定的酶转化为可溶性分泌形式,该形式具有与从人体组织中纯化的膜相关酶相同的催化特性。我们通过X射线晶体学方法确定了人CA IV分泌形式的三维结构,分辨率为2.8埃。尽管CA IV的锌结合位点和疏水底物结合口袋通常与其他哺乳动物同工酶的相似,但在活性位点的其他位置发现了独特的结构差异。两个二硫键,Cys-6-Cys-11G和Cys-23-Cys-203,稳定了N末端结构域的构象。后一个二硫键还稳定了一个活性位点环,该环包含Pro-201和Thr-202之间的顺式肽键(该环包含催化残基Thr-199)。在活性位点的另一侧,Val-131-Asp-136片段采用延伸环构象,而不是其他同工酶中发现的α-螺旋构象。最后,C末端被大量的正电表面电位包围,这可能稳定CA IV与膜带负电的磷脂头部基团的相互作用。这些结构特征是CA IV独有的,为设计针对这种特定同工酶的磺酰胺抑制剂提供了框架。